You are proving my table to be accurate.
The fact to the matter is wbt do not 100% own the patents and have co-ownership with Leti and Rice University.
Yes, WBT will be paying royalties and the below is the original base agreement with Rice University which had been re-negotiated to be pushed out by another year and the again re-negotiated to a capped arrangement, but details of terms are confidential.
Nevertheless, wbt is commercial ready as it will receive license fees and royalties based on production volumes from Skywater.
As you rightly pointed out, the below comparable table is accurate.
Company 4DS WBT 1 Technology Non-Filamentary Interface Switching ReRAM Filamentary ReRAM 2 Shares on Issue 1,479,765,442 172,326,171 3 Share Price AUD $0.038 AUD $3.74 4 Current Company Market Value AUD $56.2M AUD $644.5M 5 Patent Ownership 100% Owned Co-Ownership (Rice University & Leti) 6 Company Commercial Goal Acquistion Licensing 7 Commercial Ready Pending 1Mb ReRAM Array Q2 2023 Yes 8 Research and Development Partner IMEC LETI 9 Industry Partner Western Digital SkyWater 10 Industry Partner Market Value USD $10.4B USD $398M 11 Current Market Target Stand Alone NVM Embeded NVM 12 Technology Market DRAM FLASH 13 Technology Market Value USD $110B USD $25B
- Forums
- ASX - By Stock
- 4DS
- 4DS - Anything but Charting
4DS - Anything but Charting, page-25734
-
- There are more pages in this discussion • 4,984 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DS (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.8¢ |
Change
-0.002(2.22%) |
Mkt cap ! $155.1M |
Open | High | Low | Value | Volume |
9.0¢ | 9.1¢ | 8.8¢ | $255.0K | 2.855M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 201205 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 201205 | 0.088 |
8 | 774567 | 0.087 |
5 | 576804 | 0.086 |
13 | 1368456 | 0.085 |
2 | 220000 | 0.084 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 20000 | 1 |
0.090 | 313381 | 2 |
0.091 | 11445 | 1 |
0.092 | 683892 | 3 |
0.093 | 181179 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
4DS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online